Michael Liontos

80 Vasilissis Sofias Avenue
Athens, ESYE31 11528, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition.

Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition.

Journal: Frontiers in oncology

Published: April 21, 2024

Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.

Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.

Journal: F1000Research

Published: October 02, 2023

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.

Journal: Frontiers in oncology

Published: January 03, 2022

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review.

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review.

Journal: Annals of translational medicine

Published: January 13, 2021

Pembrolizumab in endometrial cancer: Where we stand now.

Pembrolizumab in endometrial cancer: Where we stand now.

Journal: Oncology letters

Published: December 24, 2020

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.

Journal: The Lancet. Oncology

Published: April 29, 2020

Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer.

Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer.

Journal: Case reports in oncology

Published: April 02, 2020

Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.

Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.

Journal: Breast care (Basel, Switzerland)

Published: March 01, 2020

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.

Journal: Journal of oncology

Published: February 17, 2020

Supportive medication in cancer during pregnancy.

Supportive medication in cancer during pregnancy.

Journal: BMC pregnancy and childbirth

Published: February 12, 2020

Controversies in preoperative bowel preparation in gynecologic and gynecologic oncology surgery: a review of the literature.

Controversies in preoperative bowel preparation in gynecologic and gynecologic oncology surgery: a review of the literature.

Journal: Archives of gynecology and obstetrics

Published: September 10, 2019

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 29, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026